ATP13A5
Basic information
Region (hg38): 3:193274789-193378820
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ATP13A5 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 63 | 65 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 63 | 5 | 2 |
Variants in ATP13A5
This is a list of pathogenic ClinVar variants found in the ATP13A5 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-193275045-CA-C | Benign (Jun 23, 2018) | |||
3-193275056-A-G | not specified | Uncertain significance (Jun 02, 2023) | ||
3-193275070-G-C | not specified | Uncertain significance (Nov 13, 2024) | ||
3-193275109-T-C | not specified | Uncertain significance (Feb 28, 2024) | ||
3-193275141-G-C | not specified | Uncertain significance (Dec 09, 2023) | ||
3-193275158-C-T | not specified | Uncertain significance (Nov 13, 2024) | ||
3-193275178-T-C | not specified | Uncertain significance (Dec 08, 2023) | ||
3-193275247-A-C | not specified | Uncertain significance (Aug 16, 2021) | ||
3-193276755-C-T | not specified | Uncertain significance (Aug 02, 2021) | ||
3-193276770-A-G | not specified | Uncertain significance (Apr 07, 2022) | ||
3-193276811-G-A | not specified | Uncertain significance (Aug 12, 2024) | ||
3-193279410-A-G | not specified | Uncertain significance (May 20, 2024) | ||
3-193279433-A-G | not specified | Uncertain significance (Nov 08, 2021) | ||
3-193284915-G-T | not specified | Uncertain significance (Oct 12, 2024) | ||
3-193289938-A-G | Likely benign (Jan 01, 2023) | |||
3-193289943-T-A | not specified | Uncertain significance (Jul 05, 2024) | ||
3-193289944-C-G | not specified | Uncertain significance (Aug 02, 2023) | ||
3-193289985-G-A | not specified | Uncertain significance (Sep 22, 2023) | ||
3-193289993-G-A | not specified | Uncertain significance (Aug 08, 2023) | ||
3-193289994-G-C | not specified | Uncertain significance (Nov 26, 2024) | ||
3-193290053-G-A | not specified | Uncertain significance (Nov 09, 2023) | ||
3-193301249-C-T | not specified | Uncertain significance (Jan 31, 2022) | ||
3-193301257-G-A | not specified | Uncertain significance (Oct 14, 2023) | ||
3-193301288-C-T | not specified | Uncertain significance (Dec 18, 2023) | ||
3-193301299-C-T | not specified | Uncertain significance (Mar 21, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ATP13A5 | protein_coding | protein_coding | ENST00000342358 | 30 | 104054 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.41e-49 | 1.40e-8 | 119078 | 99 | 6571 | 125748 | 0.0269 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.606 | 601 | 644 | 0.933 | 0.0000325 | 7935 |
Missense in Polyphen | 201 | 249.43 | 0.80583 | 3234 | ||
Synonymous | 0.664 | 227 | 240 | 0.945 | 0.0000126 | 2313 |
Loss of Function | -0.445 | 72 | 68.0 | 1.06 | 0.00000323 | 842 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0260 | 0.0254 |
Ashkenazi Jewish | 0.0103 | 0.0103 |
East Asian | 0.00187 | 0.00185 |
Finnish | 0.0501 | 0.0499 |
European (Non-Finnish) | 0.0389 | 0.0389 |
Middle Eastern | 0.00187 | 0.00185 |
South Asian | 0.00892 | 0.00883 |
Other | 0.0268 | 0.0262 |
dbNSFP
Source:
- Pathway
- Ion channel transport;Transport of small molecules;Ion transport by P-type ATPases
(Consensus)
Recessive Scores
- pRec
- 0.0798
Intolerance Scores
- loftool
- 0.263
- rvis_EVS
- 2.04
- rvis_percentile_EVS
- 97.72
Haploinsufficiency Scores
- pHI
- 0.0882
- hipred
- N
- hipred_score
- 0.155
- ghis
- 0.442
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.125
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | High | High | High |
Primary Immunodeficiency | High | High | High |
Cancer | High | High | High |
Mouse Genome Informatics
- Gene name
- Atp13a5
- Phenotype
- hematopoietic system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); immune system phenotype;
Gene ontology
- Biological process
- cellular calcium ion homeostasis;ion transmembrane transport;ATP hydrolysis coupled cation transmembrane transport
- Cellular component
- plasma membrane;integral component of membrane
- Molecular function
- ATP binding;cation-transporting ATPase activity;metal ion binding